Logo image of FRTA

FORTERRA INC (FRTA) Stock Fundamental Analysis

USA - NASDAQ:FRTA - Common Stock

24
+0.93 (+4.03%)
Last: 3/17/2022, 8:00:00 PM
23.99
-0.01 (-0.04%)
After Hours: 3/17/2022, 8:00:00 PM
Fundamental Rating

2

FRTA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 13 industry peers in the Construction Materials industry. FRTA has a bad profitability rating. Also its financial health evaluation is rather negative. FRTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FRTA had positive earnings in the past year.
FRTA Yearly Net Income VS EBIT VS OCF VS FCFFRTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M

1.2 Ratios

Industry RankSector Rank
ROA 6.56%
ROE 36.46%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRTA Yearly ROA, ROE, ROICFRTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -50 -100 -150

1.3 Margins

Industry RankSector Rank
OM 11.69%
PM (TTM) 6.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FRTA Yearly Profit, Operating, Gross MarginsFRTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, FRTA has more shares outstanding
FRTA has a better debt/assets ratio than last year.
FRTA Yearly Shares OutstandingFRTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M
FRTA Yearly Total Debt VS Total AssetsFRTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.39 indicates that FRTA is not a great score, but indicates only limited risk for bankruptcy at the moment.
FRTA has a Debt/Equity ratio of 3.20. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Altman-Z 2.39
ROIC/WACCN/A
WACCN/A
FRTA Yearly LT Debt VS Equity VS FCFFRTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M 800M 1B

2.3 Liquidity

FRTA has a Current Ratio of 2.15. This indicates that FRTA is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.25 indicates that FRTA should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.25
FRTA Yearly Current Assets VS Current LiabilitesFRTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

FRTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.57%, which is quite impressive.
FRTA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.53%.
The Revenue has been growing slightly by 6.38% on average over the past years.
EPS 1Y (TTM)79.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.12%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y7.89%
Revenue growth 5Y6.38%
Sales Q2Q%23.91%

3.2 Future

FRTA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.63% yearly.
The Revenue is expected to grow by 1.94% on average over the next years.
EPS Next Y17.88%
EPS Next 2Y15.65%
EPS Next 3Y15.92%
EPS Next 5Y16.63%
Revenue Next Year2.44%
Revenue Next 2Y2.45%
Revenue Next 3Y1.77%
Revenue Next 5Y1.94%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
FRTA Yearly Revenue VS EstimatesFRTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
FRTA Yearly EPS VS EstimatesFRTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.37, which indicates a correct valuation of FRTA.
FRTA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.02.
FRTA is valuated correctly with a Price/Forward Earnings ratio of 12.19.
When comparing the Price/Forward Earnings ratio of FRTA to the average of the S&P500 Index (22.57), we can say FRTA is valued slightly cheaper.
Industry RankSector Rank
PE 14.37
Fwd PE 12.19
FRTA Price Earnings VS Forward Price EarningsFRTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.69
FRTA Per share dataFRTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

FRTA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FRTA's earnings are expected to grow with 15.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.8
PEG (5Y)N/A
EPS Next 2Y15.65%
EPS Next 3Y15.92%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FRTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORTERRA INC

NASDAQ:FRTA (3/17/2022, 8:00:00 PM)

After market: 23.99 -0.01 (-0.04%)

24

+0.93 (+4.03%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)N/A N/A
Earnings (Next)04-26 2022-04-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.72%
Ins Owner Change0%
Market Cap1.61B
Analysts80
Price Target24.48 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.37
Fwd PE 12.19
P/S 0.86
P/FCF N/A
P/OCF N/A
P/B 5.04
P/tB N/A
EV/EBITDA 8.69
EPS(TTM)1.67
EY6.96%
EPS(NY)1.97
Fwd EY8.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.75
BVpS4.76
TBVpSN/A
PEG (NY)0.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.56%
ROE 36.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 11.69%
PM (TTM) 6.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.25
Altman-Z 2.39
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.12%
EPS Next Y17.88%
EPS Next 2Y15.65%
EPS Next 3Y15.92%
EPS Next 5Y16.63%
Revenue 1Y (TTM)16.53%
Revenue growth 3Y7.89%
Revenue growth 5Y6.38%
Sales Q2Q%23.91%
Revenue Next Year2.44%
Revenue Next 2Y2.45%
Revenue Next 3Y1.77%
Revenue Next 5Y1.94%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A